ArticleiScience2026
scUmaper: An automated framework for doublet removal and cell-type annotation in single-cell transcriptomics.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single-cell RNA sequencing can resolve cellular heterogeneity but is sensitive to heterotypic doublets and often requires expert-driven preprocessing and annotation. We developed single cell utility matrices processing engine (scUmaper), an R/Seurat-native workflow that integrates quality control, biologically grounded doublet filtering, and marker-library-based cell-type annotation. scUmaper codifies lineage-marker incompatibility rules and applies global clustering followed by within-lineage re-clustering to reveal anomalous subclusters with implausible cross-lineage co-expression. Across six public human organ datasets, scUmaper removed additional high-confidence heterotypic doublets that were retained by simulation-based approaches and achieved annotation agreement comparable to or higher than commonly used R-based baselines, with competitive runtime. Stress tests with simulated ambient RNA contamination and reduced sequencing depth showed stable outputs under moderate degradation. scUmaper provides an interpretable and extensible framework that lowers barriers for reproducible single-cell RNA sequencing (scRNA-seq) analysis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.